ARCH VENTURE FUND VIII, L.P. - HOMOLOGY MEDICINES, INC. -- SCHEDULE 13G/A(#1)

Company

Q32 Bio Inc.

Filed

February 13, 2020

Accession Number

0001072613-20-000098